Table 2.
Treatment effect size of PTSD in various therapies from current review.
Type | Therapy | Treatment effect size |
---|---|---|
Trauma-focused psychotherapy | Prolonged exposurea | Hedges' g = 1.08 (posttreatment); 0.68 (follow-up) |
Cognitive processing therapyb | Hedges' g = 1.24 (posttreatment); 0.90 (follow-up) | |
Eye movement desensitization reprocessingc | SMD = 1.40 | |
Brief eclectic psychotherapy | Not available | |
Narrative exposure therapyc | SMD = 1.31 | |
Non-trauma-focused psychotherapy | Stress inoculation trainingd | SMD = 1.26 (posttreatment); 0.40 (follow-up) |
Mindfulness-based therapye | Hedges' g = 0.44 | |
Present-Centered Therapyf | SMD = 0.84 | |
Interpersonal Psychotherapyd | SMD = 0.15 (posttreatment); 0.25 (follow-up) | |
Pharmacotherapy | Sertralinec | SMD = 0.20 |
Paroxetinec | SMD = 0.44 | |
Fluoxetinec | SMD = 0.28 | |
Venlafaxined | SMD = 0.32–1.78 | |
Psychopharmacotherapy | MDMA assisted psychotherapyg | Hedges' g = 1.17 |
Effect size chose meta-analytic data of therapy vs. control or randomized control trials. Positive value meansthe therapy performed better than control.
PTSD: post-traumatic stress disorder; SMD: standardized mean difference.
From Powers et al., 2015.
From Asmundson et al., 2019.
From Forman-Hoffman et al., 2018.
From Lee et al., 2016.
From Hopwood and Schutte 2017.
From Belsher et al., 2019.
From Amoroso and Workman 2016.